Hangzhou Biotest Biotech Co.,Ltd. (688767.SS)
CNY 32.67
(0.28%)
CNY 32.67
(0.28%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 442.11 Million | 1.9 Billion | 1.81 Billion | 865.37 Million | 208.84 Million | 180.3 Million |
| Cost of Revenue | 269.59 Million | 884.77 Million | 693.93 Million | 218.18 Million | 119.51 Million | 110.96 Million |
| Gross Profit | 172.51 Million | 1.01 Billion | 1.12 Billion | 647.18 Million | 89.32 Million | 69.33 Million |
| Operating Expenses | 105.69 Million | 196.3 Million | 142.05 Million | 109.06 Million | 54.19 Million | 41.7 Million |
| Selling, General and Administrative Expenses | 31.48 Million | 53.92 Million | 42.82 Million | 47.87 Million | 28.74 Million | 23.37 Million |
| Research and Development Expenses | 80.47 Million | 108.2 Million | 61.92 Million | 41.32 Million | 16.84 Million | 9.66 Million |
| Other Expenses | -107.66 Million | 34.16 Million | 37.29 Million | 19.86 Million | 8.61 Million | -13.31 Thousand |
| Cost and Expenses | 325.28 Million | 1.08 Billion | 835.99 Million | 327.24 Million | 173.71 Million | 152.67 Million |
| Operating Income | 116.82 Million | 914.34 Million | 966.52 Million | 513.08 Million | 32.23 Million | 22.54 Million |
| Interest Expense | 838.55 Thousand | 194.48 Thousand | 678.06 Thousand | 467.11 Thousand | 862.5 Thousand | 966.57 Thousand |
| Income Tax Expense | 10.57 Million | 128.31 Million | 132.87 Million | 79.35 Million | 4.33 Million | 3.68 Million |
| Earnings before Tax | 115.87 Million | 901.89 Million | 968.62 Million | 514.32 Million | 32.26 Million | 22.53 Million |
| Net Income | 106.6 Million | 773.63 Million | 833.59 Million | 435.14 Million | 28.22 Million | 18.9 Million |
| Earnings Per Share Basic | 1.00 | 7.25 | 7.81 | 4.08 | 0.26 | 0.24 |
| Earnings Per Share Diluted | 1.00 | 7.25 | 7.81 | 4.08 | 0.26 | 0.24 |
| Weighted Average Shares Outstanding | 106.6 Million | 106.66 Million | 106.66 Million | 106.66 Million | 106.66 Million | 78.77 Million |
| Weighted Average Shares Outstanding (Diluted) | 106.6 Million | 106.66 Million | 106.66 Million | 106.66 Million | 106.66 Million | 78.77 Million |
| Gross Margin | 0.39 | 0.53 | 0.62 | 0.75 | 0.43 | 0.38 |
| EBIT Margin | 0.33 | 0.52 | 0.55 | 0.61 | 0.20 | 0.19 |
| Profit Margin | 0.24 | 0.41 | 0.46 | 0.50 | 0.14 | 0.10 |
| EBITDA | 146.45 Million | 926.41 Million | 980.61 Million | 520.91 Million | 38.41 Million | 27.65 Million |
| Earnings Before Tax Margin | 0.26 | 0.48 | 0.53 | 0.59 | 0.15 | 0.13 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 120.18 Million | 128.07 Million | 135.62 Million | 442.36 Million | 129.87 Million | 100.16 Million |
| Cost of Revenue | 63.79 Million | 65.81 Million | 74.82 Million | 219.59 Million | 38.21 Million | 56.26 Million |
| Gross Profit | 56.38 Million | 62.25 Million | 60.8 Million | 222.77 Million | 91.66 Million | 43.9 Million |
| Operating Expenses | 40.83 Million | 44.03 Million | 32.94 Million | 320.67 Million | 36.68 Million | 34.25 Million |
| Selling, General and Administrative Expenses | 23.44 Million | 23.16 Million | 17.49 Million | - | -5.63 Million | 33.63 Million |
| Research and Development Expenses | 13.58 Million | 15.71 Million | 14.64 Million | - | 36.72 Million | 15.15 Million |
| Other Expenses | -17.38 Million | -5.16 Million | 1437.07 | -320.67 Million | -13.31 Million | 7.59 Million |
| Cost and Expenses | 104.62 Million | 109.85 Million | 107.76 Million | 320.67 Million | 74.89 Million | 90.51 Million |
| Operating Income | 15.55 Million | 18.22 Million | 44.53 Million | 121.68 Million | 25.72 Million | 25.79 Million |
| Interest Expense | 4377.04 | - | - | 136.61 Thousand | - | - |
| Income Tax Expense | 2.08 Million | 5.74 Million | 5 Million | 10.57 Million | -2.82 Million | 4.29 Million |
| Earnings before Tax | 18.46 Million | 36.82 Million | 44.53 Million | 120.73 Million | 12.41 Million | 33.39 Million |
| Net Income | 17.03 Million | 32.54 Million | 39.63 Million | 106.6 Million | 15.07 Million | 29.92 Million |
| Earnings Per Share Basic | 0.16 | 0.31 | 0.38 | - | 0.18 | 0.28 |
| Earnings Per Share Diluted | 0.16 | 0.31 | 0.38 | - | 0.18 | 0.28 |
| Weighted Average Shares Outstanding | 104.51 Million | 104.55 Million | 104.29 Million | 106.6 Million | 108.66 Million | 106.66 Million |
| Weighted Average Shares Outstanding (Diluted) | 104.51 Million | 104.55 Million | 104.29 Million | 106.6 Million | 108.66 Million | 106.66 Million |
| Gross Margin | 0.47 | 0.49 | 0.45 | 0.50 | 0.71 | 0.44 |
| EBIT Margin | 0.15 | 0.21 | 0.21 | - | 1.02 | -0.38 |
| Profit Margin | 0.14 | 0.25 | 0.29 | 0.24 | 0.12 | 0.30 |
| EBITDA | 18.46 Million | 26.34 Million | 28.07 Million | - | 132.39 Million | -37.76 Million |
| Earnings Before Tax Margin | 0.13 | 0.14 | 0.33 | 0.28 | 0.20 | 0.26 |
PHRRF
NSRCF
SHOORA
DOC
BEC
APCOTEXIND